PPARG2 Pro12Ala and ADAMTS9 rs4607103 as “insulin resistance loci” and “insulin secretion loci” in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4
- 560 Downloads
We investigated cross-sectionally whether the type 2 diabetes (T2DM) risk alleles of rs1801282 (PPARG2) and rs4607103 (ADAMTS9) were associated with T2DM and/or insulin sensitivity (IS) and beta cell function (βF) in Italians without and with newly diagnosed T2DM. In 676 nondiabetic subjects (336 NGR and 340 IGR) from the GENFIEV study and in 597 patients from the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS), we (1) genotyped rs1801282 and rs4607103, (2) assessed βF by C-peptide/glucose modeling after OGTT, and (3) assessed IS by HOMA-IR in both studies and by euglycemic insulin clamp in VNDS only. Logistic, linear, and two-stage least squares regression analyses were used to test (a) genetic associations with T2DM and with pathophysiological phenotypes, (b) causal relationships of the latter ones with T2DM by a Mendelian randomization design. Both SNPs were associated with T2DM. The rs4607103 risk allele was associated to impaired βF (p < 0.01) in the GENFIEV study and in both cohorts combined. The rs1801282 genotype was associated with IS both in the GENFIEV study (p < 0.03) and in the VNDS (p < 0.03), whereas rs4607103 did so in the VNDS only (p = 0.01). In a Mendelian randomization design, both HOMA-IR (instrumental variables: rs1801282, rs4607103) and βF (instrumental variable: rs4607103) were related to T2DM (p < 0.03–0.01 and p < 0.03, respectively). PPARG2 and ADAMTS9 variants are both associated with T2DM and with insulin resistance, whereas only ADAMTS9 may be related to βF. Thus, at least in Italians, they may be considered bona fide “insulin resistance genes”.
KeywordsType 2 diabetes Insulin resistance PPARG ADAMTS9
This study was supported in part by an EFSD/Novartis grant (to RCB), research grants of University of Verona (to RCB and EB), and a grant of the Società Italiana di Diabetologia for the GENFIEV Study (to SDP). The superb technical help of Monica Zardini and Federica Moschetta is gratefully acknowledged (Department of Medicine, University of Verona, Verona, Italy). PPARG2 and ADAMTS9 genotyping was performed with XBead Reader of the Center of Functional Genomics of University of Verona, under the supervision of Massimo Delledonne and Alberto Ferrarini, whose contributions are gratefully acknowledged.
Conflict of interest
None of the authors declared any conflict of interest.
- 1.Trombetta M, Calì A, Vettore M, Caruso B, Dorizzi R, Avogaro A, Bonora E, Bonadonna RC (2011) Type 2 diabetes mellitus: a disease of the governance of the glucose-insulin system. An experimental metabolic control analysis study. Nutrition, metabolism and cardiovascular disease in pressGoogle Scholar
- 12.Vanttinen M, Nuutila P, Pihlajamaki J et al (2005) The effect of the Ala12 allele of the peroxisome proliferator-activated receptor-gamma2 gene on skeletal muscle glucose uptake depends on obesity: a positron emission tomography study. J Clin Endocrinol Metab 90:4249–4254PubMedCrossRefGoogle Scholar
- 20.Grarup N, Andersen G, Krarup NT et al (2008) Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes. Diabetes 57:2534–2540PubMedCrossRefGoogle Scholar
- 24.Bianchi C, Miccoli R, Bonadonna RC et al. (2010) Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. Nutr Metab Cardiovasc Dis 21(9):699–705Google Scholar
- 27.Bonadonna RC, Heise T, Arbet-Engels C et al (2010) Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study. J Clin Endocrinol Metab 95:5028–5036PubMedCrossRefGoogle Scholar
- 31.Gallwitz B, Kazda C, Kraus P, Nicolay C, Schernthaner G (2011) Contribution of insulin deficiency and insulin resistance to the development of type 2 diabetes: nature of early stage diabetes. Acta Diabetol. doi: 1007/s00592-011-0319-4